Valion Bio Inc's Comment on Sales, Marketing and Customers
Tivic has exited the consumer health technology sector and suspended development of its prescription bioelectronic products to focus on Entolimod and its next-generation compound, Entolasta, targeting acute radiation syndrome and oncology-related conditions including neutropenia, thrombocytopenia, and mucositis. The company primarily targets government procurement markets and collaborates with agencies such as the White House, BARDA, DoW/DTRA, FDA, NIH, and NIAID. Through its subsidiary Velocity Bioworks, Tivic operates a biomanufacturing facility that supports CGMP manufacturing for regulatory submissions. Tivic discontinued sales of its ClearUP sinus device and halted development of its cervical vagus nerve stimulation platform to concentrate on the TLR5 platform and Velocity Bioworks. Customers and partners mentioned in filings include 3i, LP, Cleveland BioLabs, Scorpius Biomanufacturing, Statera Biopharma, Inc., and Velocity Bioworks.
Valion Bio Inc’s Comment on Sales, Marketing and Customers
Tivic has exited the consumer health technology sector and suspended development of its prescription bioelectronic products to focus on Entolimod and its next-generation compound, Entolasta, targeting acute radiation syndrome and oncology-related conditions including neutropenia, thrombocytopenia, and mucositis. The company primarily targets government procurement markets and collaborates with agencies such as the White House, BARDA, DoW/DTRA, FDA, NIH, and NIAID. Through its subsidiary Velocity Bioworks, Tivic operates a biomanufacturing facility that supports CGMP manufacturing for regulatory submissions. Tivic discontinued sales of its ClearUP sinus device and halted development of its cervical vagus nerve stimulation platform to concentrate on the TLR5 platform and Velocity Bioworks. Customers and partners mentioned in filings include 3i, LP, Cleveland BioLabs, Scorpius Biomanufacturing, Statera Biopharma, Inc., and Velocity Bioworks.
Sources:
Valion Bio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Valion Bio Inc’s corporate clients.
For your research, we’ve provided 9 tables on Valion Bio Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
